Search research articles
Contact Us
Filters
Showing results (111-120 of 289) with videos related to
Page
of 29
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells
L M Levasseur, W R Greco, Y M Rustum, et al.
Journal of Child Neurology
|
December 11, 1999
Epilepsy with myoclonic absences with early onset: a follow-up study
A Verrotti, R Greco, F Chiarelli, et al.
In Vitro Cellular & Developmental Biology. Animal
|
September 4, 1999
Parabolic growth patterns in 96-well plate cell growth experiments
H M Faessel, L M Levasseur, H K Slocum, et al.
Clinical and Experimental Medicine
|
February 9, 2002
Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1
A Verrotti, F Basciani, D Trotta, et al.
European Review for Medical and Pharmacological Sciences
|
December 27, 2011
Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia?
M Senatore, G Coppolino, T Papalia, et al.
Cephalalgia : an International Journal of Headache
|
July 22, 2005
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine
C Tassorelli, R Greco, P Morazzoni, et al.
International Journal of Oncology
|
July 10, 2003
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells
Hélène M Faessel, Harry K Slocum, Youcef M Rustum, et al.
Cancer Research
|
December 29, 1998
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance
L M Levasseur, H K Slocum, Y M Rustum, et al.
Biochemical Pharmacology
|
February 10, 1999
Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin -6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034): comparison across sensitive and resistant human tumor cell lines
H M Faessel, H K Slocum, Y M Rustum, et al.
Transplantation Proceedings
|
June 11, 2010
Impact of continuous value of body mass index on graft loss in overweight patients
T Papalia, R Greco, D Lofaro, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 289) with videos related to
Sort By:
Page
of 29
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells
L M Levasseur, W R Greco, Y M Rustum, et al.
Journal of Child Neurology
|
December 11, 1999
Epilepsy with myoclonic absences with early onset: a follow-up study
A Verrotti, R Greco, F Chiarelli, et al.
In Vitro Cellular & Developmental Biology. Animal
|
September 4, 1999
Parabolic growth patterns in 96-well plate cell growth experiments
H M Faessel, L M Levasseur, H K Slocum, et al.
Clinical and Experimental Medicine
|
February 9, 2002
Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1
A Verrotti, F Basciani, D Trotta, et al.
European Review for Medical and Pharmacological Sciences
|
December 27, 2011
Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia?
M Senatore, G Coppolino, T Papalia, et al.
Cephalalgia : an International Journal of Headache
|
July 22, 2005
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine
C Tassorelli, R Greco, P Morazzoni, et al.
International Journal of Oncology
|
July 10, 2003
Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells
Hélène M Faessel, Harry K Slocum, Youcef M Rustum, et al.
Cancer Research
|
December 29, 1998
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance
L M Levasseur, H K Slocum, Y M Rustum, et al.
Biochemical Pharmacology
|
February 10, 1999
Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin -6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034): comparison across sensitive and resistant human tumor cell lines
H M Faessel, H K Slocum, Y M Rustum, et al.
Transplantation Proceedings
|
June 11, 2010
Impact of continuous value of body mass index on graft loss in overweight patients
T Papalia, R Greco, D Lofaro, et al.
Page
of 29